The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double‐blind, placebo‐controlled trial
Open accessAbstract
Objective: Fibromyalgia syndrome (FMS) is characterized by widespread musculoskeletal pain and lowered pain threshold. Other prominent symptoms include disordered sleep and fatigue. FMS affects an estimated 2% of the population, predominantly women. This trial was designed to evaluate the efficacy and safety of pregabalin, a novel α 2‐δ ligand, for treatment of symptoms associated with FMS. Methods: This multicenter, double‐blind, 8‐week, randomized clinical trial compared the effects of placebo with those of 150, 300, and 450 mg/day pregabalin on pain, sleep, fatigue, and health‐related quality of life in 529 patients with FMS. The primary outcome variable was the comparison of end point mean pain scores, derived from daily diary ratings of pain intensity, between each of the pregabalin treatment groups and the placebo group. Results: Pregabalin at 450 mg/day significantly reduced the average severity of pain in the primary analysis compared with placebo (−0.93 on a 0–10 scale) (P ≤ 0.001), and significantly more patients in this group had ≥50% improvement in pain at the end point (29%, versus 13% in the placebo group; P = 0.003). Pregabalin at 300 and 450 mg/day was associated with significant improvements in sleep quality, fatigue, and global measures of change. Pregabalin at 450 mg/day improved several domains of health‐related quality of life. Dizziness and somnolence were the most frequent adverse events. Rates of discontinuation due to adverse events were similar across all 4 treatment groups. Conclusion: Pregabalin at 450 mg/day was efficacious for the treatment of FMS, reducing symptoms of pain, disturbed sleep, and fatigue compared with placebo. Pregabalin was well tolerated and improved global measures and health‐related quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Self-citationA sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
Self-citationThe Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Self-citationRosenstock, J., Tuchman, M., LaMoreaux, L., & Sharma, U. (2004) · Pain · doi:10.1016/j.pain.2004.05.001 · Cited by 725
Self-citationThe prevalence and meaning of fatigue in rheumatic disease.
Wolfe, F., Hawley, D. J., & Wilson, K. (1996) · PubMed · Cited by 641
Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial
Lesser, H., Sharma, U., LaMoreaux, L., & Poole, R. M. (2004) · Neurology · doi:10.1212/01.wnl.0000145767.36287.a1 · Cited by 570
Self-citationAuxiliary subunits: essential components of the voltage-gated calcium channel complex
Arikkath, J., & Campbell, K. P. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00066-7 · Cited by 505
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., & Göthert, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00172-1 · Cited by 496
Measuring Functioning and Well-Being
Stewart, A., & Ware, J. E. (1992) · Cited by 458
Correlates of Fatigue in Older Adults with Rheumatoid Arthritis
BELZA, B. L., HENKE, C. J., YELIN, E. H., EPSTEIN, W. V., & GILLISS, C. L. (1993) · Nursing Research · doi:10.1097/00006199-199303000-00006 · Cited by 434
Bennett, R. M., Kamin, M., Karim, R., & Rosenthal, N. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00116-5 · Cited by 403
Chronic widespread pain and fibromyalgia: what we know, and what we need to know
Clauw, D. J., & Crofford, L. J. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00035-4 · Cited by 381
Self-citationPsychiatric Disorders in Patients With Fibromyalgia
Epstein, S. A., Kay, G., Clauw, D., Heaton, R., Klein, D., Krupp, L., Kuck, J., Leslie, V., Masur, D., Wagner, M., et al. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71272-7 · Cited by 375
Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial
Pande, A. C., Crockatt, J. G., Feltner, D. E., Janney, C. A., Smith, W. T., Weisler, R., Londborg, P. D., Bielski, R. J., Zimbroff, D. L., Davidson, J. R. T., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.533 · Cited by 314
Calcium Channel α2δ Subunits—Structure and Gabapentin Binding
Marais, E., Klugbauer, N., & Hofmann, F. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1243 · Cited by 262
Feltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., Liu-Dumaw, M., Carter, C. M., & Pande, A. C. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084032.22282.ff · Cited by 260
Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function
Randinitis, E. J., Posvar, E. L., Alvey, C. W., Sedman, A. J., Cook, J. A., & Bockbrader, H. N. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003251119 · Cited by 257
Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin
Dooley, D. J., Mieske, C. A., & Borosky, S. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00769-2 · Cited by 226
Okifuji, A., Turk, D., Sinclair, J. D., Starz, T. W., & Da, M. (1997) · PubMed · Cited by 220
Dooley, D. J., Donovan, C. M., & Pugsley, T. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39009-3 · Cited by 217
Fibromyalgia: The Clinical Syndrome
Wolfe, F. (1989) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00029-6 · Cited by 190
Molecular Cloning and Characterization of the Human Voltage-Gated Calcium Channel α2δ-4 Subunit
Qin, N., Yagel, S., Momplaisir, M.-L., Codd, E. E., & D'Andrea, M. R. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.485 · Cited by 186
Maneuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
Statistical Methodology in the Pharmaceutical Sciences
Berry, D. A. (2014) · CRC Press eBooks · doi:10.1201/b16950 · Cited by 138
Dubel, S. J., Altier, C., Chaumont‐Dubel, S., Lory, P., Bourinet, E., & Nargeot, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313450200 · Cited by 124
THE RELATIONSHIP BETWEEN FIBROMYALGIA AND MAJOR DEPRESSIVE DISORDER
Hudson, J. I., & Pope, H. G. (1996) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70273-8 · Cited by 122
Errante, L. D., & Petroff, O. A. C. (2003) · Seizure · doi:10.1016/s1059-1311(02)00295-9 · Cited by 113
Crofford, L. J., & Clauw, D. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10217 · Cited by 109
Self-citationFibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome
Goldenberg, D. L. (1995) · Current Opinion in Rheumatology · doi:10.1097/00002281-199503000-00011 · Cited by 81
The role of psychiatric disorders in fibromyalgia
McBeth, J., & Silman, A. J. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0011-8 · Cited by 64
Metabolic disposition of pregabalin in healthy volunteers
Corrigan, B., Pool, W. F., Posvar, E. L., Strand, J. C., Alvey, C. W., Radulovic, L. L., & Bockbrader, H. N. (2001) · Clinical Pharmacology & Therapeutics · Cited by 58
Rational and targeted pharmacologic treatment of fibromyalgia
Barkhuizen, A. (2002) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(01)00011-4 · Cited by 45
Richards, S. (2000) · British journal of rheumatology · doi:10.1093/rheumatology/39.4.343 · Cited by 41
Fibromyalgia, chronic fatigue syndrome, and myofascial pain
Goldenberg, D. L. (1996) · Current Opinion in Rheumatology · doi:10.1097/00002281-199603000-00006 · Cited by 35
Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome
Goldenberg, D. L. (1993) · Current Opinion in Rheumatology · doi:10.1097/00002281-199305020-00013 · Cited by 26
Statistical Methodology in the Pharmaceutical Sciences.
Ware, J. H., & Berry, D. A. (1991) · Journal of the American Statistical Association · doi:10.2307/2289748 · Cited by 22
Cited by
Morin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Pregabalin for acute and chronic pain in adults
Moore, R. A., Straube, S., Wiffen, P. J., Derry, S., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub2 · Cited by 762
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Treatment of chronic non-cancer pain
Turk, D. C., Wilson, H. D., & Cahana, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60402-9 · Cited by 716
Taylor, C. P., Angelotti, T., & Fauman, E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 565
Metadata
- Authors
- Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P., LaMoreaux, L. K., Martin, S. A., Sharma, U., & Pregabalin 1008‐105 Study Group
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-04
- Volume
- 52
- Issue
- 4
- Pages
- 1264-1273
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1992436256
- Cited by
- 654
- References
- 44
- FWCI
- 34.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.